Breaks Categories: News

WednesdayAug 21, 2024 12:40 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Interim Animal Study Results Supporting Potential Utility of DehydraTECH-CBD in Diabetes Control

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced receipt of blood glucose results from weeks 4 and 8 of its ongoing animal study WEIGHT-A24-1. The study is underway using diabetic, pre-conditioned Zucker rats. The results showed that DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A and B) were the top performers in the study at day 56, reducing blood sugar levels by 2.50%, 1.90% and 1.53% respectively. These results appear to support Lexaria’s belief that DehydraTECH-CBD may have utility, particularly if used together with a GLP-1 drug, in diabetic control. Additionally, select DehydraTECH-CBD…

Continue Reading

WednesdayAug 21, 2024 11:57 am

NetworkNewsBreaks – InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary to Begin Production of All-New Class 4 Commercial Truck in September

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that Bollinger Motors, its subsidiary, intends to begin production of saleable units of the Bollinger B4 Chassis Cab, an all-new Class 4 commercial EV truck, on September 16, 2024. Bollinger Motors is partnering on production with Roush Industries, which provides contract manufacturing services from its facility in Livonia, Michigan. According to the announcement, deliveries and revenue recognition of the B4 EV truck is expected to begin in October 2024. “We are already experiencing strong momentum in the market from important customers throughout the country,” commented Jim Connelly, chief…

Continue Reading

WednesdayAug 21, 2024 11:57 am

NetworkNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Completes Manufacture, Filling of Intranasal Device for Use in Upcoming Clinical Trial

Oragenics (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, has completed its spray-dried formulation and filling of the nasal device for its lead candidate, ONP-002, for the treatment of concussion. A new chemical entity, ONP-002 targets the brain through delivery into the nasal cavity. According to the announcement, the prefilled formulation will be used to provide dosing for the upcoming phase 2a clinical trial in concussed patients. “In preparing for the phase 2a study, we wanted to ensure that ONP-002 could be formulated as a nanoparticle and delivered intranasally as a…

Continue Reading

WednesdayAug 21, 2024 11:04 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuances

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary small molecule drug candidates, today announced its receipt of three patents granted in the U.S., strengthening its patent portfolio. The issued patents include one for its formulation and method of use in the treatment of epidermolysis bullosa and related connective tissue disorders, one for biosynthesis manufacturing processes and one for an ocular drug delivery formulation. As of August 20, 2024, InMed has a total of 13 patent families covering new chemical entities, formulations, manufacturing processes and methods of use. “We are pleased to…

Continue Reading

WednesdayAug 21, 2024 10:57 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, has closed on its previously announced loan restructuring agreement. According to the announcement, the agreement is with the European Investment Bank (“EIB”) and includes an amendment. Specifically, the agreement notes that “in connection with the transaction, an amount equal to approximately EUR 26.6 million (equal to approximately $29 million), including interest accrued to date, owed by the company to the EIB under the finance contract was converted into 1,000 preferred shares, no…

Continue Reading

WednesdayAug 21, 2024 10:48 am

NetworkNewsBreaks – reAlpha Tech Corp. (NASDAQ: AIRE) Unveils AI-Powered Super App Designed to Provide Buyers with All Tools Needed to Purchase Home

reAlpha Tech (NASDAQ: AIRE), a real estate technology company developing and commercializing artificial intelligence (“AI”) technologies, has launched reAlpha. According to the announcement, the Super App is designed to bring an end-to-end, commission-free, real estate experience to users’ mobile devices. The company noted that the Super App is an addition to its online platform, combining Claire, reAlpha’s generative-AI buyer’s agent with licensed human-agent support and a suite of homebuying tools, such as title and escrow agent services. As part of the launch, the name of the Super App was changed from Claire to reAlpha, although Claire will remain as the…

Continue Reading

WednesdayAug 21, 2024 10:34 am

NetworkNewsBreaks – MoneyShow Expands Ongoing Collaboration with IBN to Include All Remaining Events in 2024

MoneyShow, a leading producer of street-smart financial conferences for investors, traders, and financial advisors, has re-engaged IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, to serve as an Official Media Partner for all its remaining events this year. The re-engagement expands MoneyShow’s ongoing collaboration with IBN. IBN and MoneyShow will collaborate on the following events: Powerful Investing and Trading Strategies (August 20-22, 2024), The MoneyShow Toronto (September 13-14, 2024), Income, Growth, and Value (September 17-19, 2024), MoneyShow Orlando (October 17-19, 2024), Alternative Investing Virtual Expo (November 12-14, 2024), and MoneyShow Masters Symposium Sarasota (December 5-7, 2024). “During the last…

Continue Reading

WednesdayAug 21, 2024 10:29 am

NetworkNewsBreaks – Accredited Solutions Inc. (OTC: ASII) Outlines Strategic Five-Year Plan to Reach $750M in Revenue

Accredited Solutions (OTC: ASII), the parent company of Diamond Creek Water, has outlined a focused five-year plan to achieve $750 million in annual revenue. The outline is included in documents the company filed with the U.S. Securities Exchange Commission (“SEC”). According to the announcement, the strategic plan includes both synergistic acquisitions and organic growth initiatives in several sectors, including e-commerce, artificial intelligence (“AI”)-based e-commerce solutions, AI-powered marketing and fintech. “This five-year plan is a pivotal moment for Accredited Solutions as we embark on a journey to transform our company and achieve substantial revenue growth,” said the Accredited Solutions CEO Eduardo…

Continue Reading

WednesdayAug 21, 2024 9:35 am

NetworkNewsBreaks – GeoVax Labs Inc. (NASDAQ: GOVX) Enters $8.5M Registered Direct Offering with Institutional Investor

GeoVax Labs (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, has entered into a definitive securities purchase agreement with a certain institutional investor. The agreement is for the purchase and sale of 1,700,000 shares of the company’s common stock (or common stock equivalents), offered at $5 per share as part of a registered direct offering. The company will also issue the investor(s), in a concurrent private placement, warrants to purchase up to 1,700,000 shares of common stock. The exercise price of the warrants is also $5 per share. The warrants will be exercisable…

Continue Reading

WednesdayAug 21, 2024 8:30 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), NTT DOCOMO Report on Quantum Optimization Pilot Program Resulting in 15% Improved Mobile Network Performance

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, has partnered with NTT DOCOMO Inc., Japan’s largest mobile phone operator, to work on a quantum optimization pilot that resulted in demonstrable mobile network performance improvements. According to the announcement, the project showed a reduction in network signal congestion across base stations, with potential for more efficient signal transmission and equipment cost savings. For the collaboration, DOCOMO used D-Wave’s annealing quantum computing solutions to reduce congestion at base stations by decreasing paging signals during peak calling times…

Continue Reading